Twist Bioscience Stock Rises Following Anthropic Announcement
Twist Bioscience's stock (TWST) rose more than 15% on Wednesday after it was named as an independent evaluator by AI startup Anthropic. The announcement helped lift other biotech stocks with exposure to artificial intelligence, signaling growing investor interest in the intersection of biology and machine learning. Anthropic has selected Twist Bioscience for its role in evaluating performance metrics or capabilities within their AI systems. This partnership highlights a broader trend where biotechnology firms are increasingly being integrated into advanced technology ecosystems, potentially opening new revenue streams and research opportunities.
Tickers: $TWST